Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 362.80
Bid: 361.60
Ask: 362.00
Change: 2.80 (0.78%)
Spread: 0.40 (0.111%)
Open: 357.00
High: 364.80
Low: 357.00
Prev. Close: 360.00
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Meeting

6 Feb 2024 11:55

RNS Number : 2050C
QinetiQ Group plc
06 February 2024
 

QINETIQ GROUP PLC

6 February 2024

QINETIQ GROUP PLC

Results of General Meeting held on 6 February 2024

Poll Results of General Meeting

QinetiQ Group plc (QinetiQ) announces that the resolution proposed as an ordinary resolution at its General Meeting (GM) held on 6 February 2024 was duly passed without amendment by the requisite majority of shareholders and the results of the poll are as follows:

VOTES FOR

%

VOTES AGAINST

%

TOTAL VOTES VALIDLY CAST

% OF SHARE CAPITAL WITH VOTING RIGHTS

VOTES WITHHELD

1

To authorise the Company to make market purchases of its ordinary shares pursuant to section 701 of the Companies Act 2006

485,836,928

99.51

2,371,173

0.49

488,208,101

84.35

688,113

Notes:

1. The percentages above are rounded to two decimal places.

2. Votes "for" include discretionary votes.

3. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "for" and "against" a resolution.

4. The number of ordinary shares in issue at 6.30pm on 2 February 2024 was 578,757,121 of which none are held in treasury. Therefore the number of ordinary shares with voting rights at 6.30pm on 2 February 2024 was 578,757,121.

Results of the poll can also be viewed on QinetiQ's website: https://www.qinetiq.com/en/investors/shareholder-services/agm

Following the resolution being duly passed, the share buyback programme as previously announced on 16 January 2024 (the Programme) will commence on 7 February 2024.

The first tranche of up to £50 million will be carried out through an irrevocable non-discretionary agreement with Barclays Capital Securities Limited (Barclays) on the basis set out in the announcement of the Programme on 16 January 2024. Barclays may undertake transactions in QinetiQ shares (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or an over the counter basis) during the Programme in order to manage their market exposure under the Programme. Disclosure of such transactions will not be made by Barclays as a result of or part of the Programme, but Barclays will continue to make any disclosures they are otherwise legally required to make.

In accordance with Listing Rule 9.6.2, a copy of the resolution will be submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

For further information please contact:

John Haworth, Group Director Investor Relations: +44 (0) 7920 545841

Lindsay Walls, Group Director Communications: +44 (0) 7793 427582

James Field, Company Secretary: +44 (0) 7841 662957

QinetiQ Group plc LEI: 213800S8OBDOZMCMUW34

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMFLFELFFIRIIS
Date   Source Headline
12th Apr 202212:45 pmRNSDirector/PDMR Shareholding
10th Mar 202211:27 amRNSDirector/PDMR Shareholding
10th Feb 202211:52 amRNSDirector/PDMR Shareholding
10th Feb 202211:52 amRNSDirector/PDMR Shareholding
2nd Feb 20228:42 amRNSHolding(s) in Company
24th Jan 202211:12 amRNSDirector/PDMR Shareholding
19th Jan 20221:43 pmRNSHolding(s) in Company
18th Jan 20227:00 amRNSThird Quarter Trading Update
17th Jan 20227:00 amRNSAppointment of President and CEO of QinetiQ US
11th Jan 202211:43 amRNSDirector/PDMR Shareholding
5th Jan 20225:05 pmRNSDirector/PDMR Shareholding
20th Dec 20219:21 amRNSDirector Declaration
10th Dec 202112:42 pmRNSDirector/PDMR Shareholding
6th Dec 202112:16 pmRNSHolding(s) in Company
18th Nov 202111:04 amRNSDirector/PDMR Shareholding
17th Nov 202110:54 amRNSDirector/PDMR Shareholding
16th Nov 202111:24 amRNSDirector/PDMR Shareholding
11th Nov 20217:00 amRNSInterim Results
10th Nov 202112:12 pmRNSDirector/PDMR Shareholding
1st Nov 202111:43 amRNSBlock listing Interim Review
19th Oct 20219:16 amRNSHolding(s) in Company
14th Oct 20217:00 amRNSTrading Update
12th Oct 202110:43 amRNSDirector/PDMR Shareholding
10th Sep 20212:07 pmRNSDirector/PDMR Shareholding
31st Aug 20212:35 pmRNSDirector/PDMR Shareholding
11th Aug 20219:07 amRNSDirector/PDMR Shareholding
27th Jul 202110:46 amRNSDirectorate Change
26th Jul 20214:33 pmRNSDirector/PDMR Shareholding
21st Jul 202110:55 amRNSResult of AGM
21st Jul 20217:00 amRNSFirst Quarter Trading Update
14th Jul 20218:47 amRNSChange of AGM venue
13th Jul 20219:52 amRNSHolding(s) in Company
12th Jul 202111:12 amRNSDirector/PDMR Shareholding
2nd Jul 20217:00 amRNSChief Financial Officer succession
29th Jun 20213:49 pmRNSDirector/PDMR Shareholding
15th Jun 202110:55 amRNSAnnual Financial Report
10th Jun 202111:15 amRNSDirector/PDMR Shareholding
9th Jun 20215:01 pmRNSDirector/PDMR Shareholding
1st Jun 20219:34 amRNSTotal Voting Rights
25th May 202110:54 amRNSBlock Listing Application
20th May 20217:00 amRNSPreliminary Results
11th May 20211:53 pmRNSDirector/PDMR Shareholding
27th Apr 20212:08 pmRNSDeath of Non-Executive Director, Ian Mason
15th Apr 20212:49 pmRNSHolding(s) in Company
14th Apr 20217:00 amRNSTrading Update
12th Apr 20212:00 pmRNSDirector/PDMR Shareholding
12th Apr 20218:32 amRNSHolding(s) in Company
10th Mar 202112:23 pmRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSInvestor Seminar
16th Feb 20218:55 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.